Organization: Health Canada
Year: 2023
Month: August
Request Number: A-2023-000336
Request Summary: Adverse Drug Reactions (ADRs) for MEZAVANT. Report numbers: 001032099, E2B_06211524. ADRs for C1 ESTERASE INHIBITOR (HUMAN). Report numbers: E2B_06234973, E2B_06257555, E2B_06223464, E2B_06234247, E2B_06234712, E2B_06233235, E2B_06202939.
Disposition: Disclosed in part
Number of pages: 101